Dopamine Agonists: Clinical Trials

3 trials of Dopamine Agonists, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Recruiting 1, Unknown 1

Follow Dopamine Agonists: new trials by email Literature Review of Dopamine Agonists trials Research Report on Dopamine Agonists

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cabergoline for Episodic Migraine
Cabergoline 0.5 MG, Placebo, Cabergoline 1 MG - Migraine
Phase 2RecruitingAarhus University Hospital1502025-11-122025-11-18
L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
L-dopa, Dopamine Agonists (pramipexole, ropirinole) - Parkinson's Disease
Phase 2UnknownUniversity of Toronto402015-01-012015-01-27
Exercise Training in Dialysis Patients With Restless Legs Syndrome (RLS)
Dopamine Agonist and Exercise - Restless Legs Syndrome, End Stage Renal Disease
Phase 2CompletedUniversity of Thessaly462006-09-012010-07-05

Conditions studied

Kidney Failure, Chronic (1)  ·  Migraine Disorders (1)  ·  Motor Activity (1)  ·  Parkinson Disease (1)  ·  Restless Legs Syndrome (1)  ·  Sleep Wake Disorders (1)

Sponsors

Aarhus University Hospital (1)  ·  University of Thessaly (1)  ·  University of Toronto (1)

Countries

Canada (1)  ·  Denmark (1)  ·  Greece (1)

Top investigators

Alfonso Fasano, MD, PhD (1)  ·  Giorgos K Sakkas, PhD (1)  ·  Ioannis Stefanidis, MD PhD (1)

Results publications

PMID 23929523, PMID 24024727, PMID 26262586, PMID 35018639

NIH funding

2025 (1)